Total Payments
$3,537
2024 Payments
$90.38
Companies
43
Transactions
187
Medicare Patients
743
Medicare Billing
$71,750
Payment Breakdown by Category
Food & Beverage$3,125 (88.4%)
Education$411.40 (11.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,125 | 182 | 88.4% |
| Education | $411.40 | 5 | 11.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $424.52 | 25 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $422.30 | 29 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $258.70 | 11 | $0 (2021) |
| Incyte Corporation | $195.64 | 7 | $0 (2021) |
| Janssen Biotech, Inc. | $189.56 | 7 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $183.44 | 12 | $0 (2021) |
| GENZYME CORPORATION | $180.12 | 10 | $0 (2021) |
| TerSera Therapeutics LLC | $156.12 | 4 | $0 (2021) |
| Acceleron Pharma, Inc. | $116.21 | 6 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $99.95 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90.38 | 1 | Adaptive Biotechnologies Corporation ($90.38) |
| 2021 | $3,446 | 186 | Amgen Inc. ($424.52) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/23/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $90.38 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2021 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR, TABRECTA | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $98.95 | General |
| Category: Oncology | ||||||
| 11/30/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: ONCOLOGY | ||||||
| 11/03/2021 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2021 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Oncology | ||||||
| 10/29/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2021 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ONCOLOGY | ||||||
| 10/27/2021 | Incyte Corporation | JAKAFI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $18.38 | General |
| Category: Hematology/Oncology | ||||||
| 10/25/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug), VYXEOS | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/25/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA, WELIREG | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2021 | Emmaus Medical, Inc. | Endari (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Sickle Cell | ||||||
| 10/22/2021 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: Hematology | ||||||
| 10/21/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: ONCOLOGY | ||||||
| 10/20/2021 | Acceleron Pharma, Inc. | Reblozyl (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Hematology | ||||||
| 10/18/2021 | Takeda Pharmaceuticals U.S.A., Inc. | EXKIVITY (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2021 | GENZYME CORPORATION | LIBTAYO (Biological), LIBTAYO, LIBTAYO | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Oncology | ||||||
| 10/15/2021 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Hematology/Oncology | ||||||
| 10/13/2021 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $15.07 | General |
| 10/12/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/12/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/11/2021 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 10/11/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/08/2021 | Acceleron Pharma, Inc. | Reblozyl (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 235 | 576 | $74,822 | $30,645 |
| 2022 | 3 | 196 | 365 | $43,060 | $21,045 |
| 2021 | 5 | 312 | 565 | $42,179 | $20,060 |
Total Patients
743
Total Services
1,506
Medicare Billing
$71,750
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 115 | 355 | $51,990 | $20,689 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 92 | 180 | $16,072 | $6,906 | 43.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 17 | 29 | $5,452 | $2,449 | 44.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 12 | $1,308 | $601.92 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 97 | 228 | $28,728 | $14,150 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 83 | 112 | $9,632 | $4,576 | 47.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 16 | 25 | $4,700 | $2,318 | 49.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 133 | $19,418 | $10,162 | 52.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 101 | 132 | $13,068 | $7,242 | 55.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 89 | 176 | $4,789 | $1,360 | 28.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 20 | 22 | $2,354 | $773.23 | 32.8% |
| 82565 | Blood creatinine level | Office | 2021 | 40 | 102 | $2,550 | $522.24 | 20.5% |
About Sara Covert, NP
Sara Covert, NP is a Oncology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2020. The National Provider Identifier (NPI) number assigned to this provider is 1780292995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sara Covert, NP has received a total of $3,537 in payments from pharmaceutical and medical device companies, with $90.38 received in 2024. These payments were reported across 187 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($3,125).
As a Medicare-enrolled provider, Covert has provided services to 743 Medicare beneficiaries, totaling 1,506 services with total Medicare billing of $71,750. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Oncology
- Other Specialties Nurse Practitioner
- Location Indianapolis, IN
- Active Since 07/14/2020
- Last Updated 03/21/2021
- Taxonomy Code 163WX0200X
- Entity Type Individual
- NPI Number 1780292995
Products in Payments
- IMBRUVICA (Drug) $258.70
- JEVTANA (Drug) $193.48
- ERLEADA (Drug) $174.49
- KEYTRUDA (Biological) $165.21
- KISQALI (Drug) $163.86
- LUMAKRAS (Drug) $135.00
- Nplate (Biological) $120.27
- Reblozyl (Drug) $116.21
- MEKINIST (Drug) $114.74
- Xermelo (Drug) $107.42
- clonoSEQ (Device) $90.38
- LIBTAYO (Biological) $86.59
- BRUKINSA (Drug) $73.24
- BLENREP (Biological) $72.12
- MONJUVI (Drug) $70.33
- INJECTAFER (Drug) $69.18
- PROMACTA (Drug) $67.44
- Tavalisse (Drug) $61.50
- Kyprolis (Drug) $60.22
- OPDIVO (Biological) $60.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Oncology Doctors in Indianapolis
Mrs. Lindsay Kaufman, Msn, Fnp-C, MSN, FNP-C
Oncology — Payments: $2,364
Oncology $2,364
Amber Floyd, Np, NP
Oncology — Payments: $442.95
Oncology $442.95
Dr. Patrick Kiel, Pharm.d, PHARM.D
Oncology
Oncology
Dr. Jennifer Bell, Pharmd, Bcop, PHARMD, BCOP
Oncology
Oncology
Susan Gordon, Pharm.d, PHARM.D
Oncology
Oncology
Roberta Hernandez, Rph, RPH
Oncology
Oncology